PicoCELA (PCLA) Stock Price, News & Analysis

Company Overview

PicoCELA, Inc. is a clinical-stage biotechnology company focused on the development of next-generation vaccines and immunotherapies based on its proprietary self-assembling protein nanoparticle platform. The company engineers functionalized, virus-like protein particles designed to present disease-relevant antigens in their native conformation, with the goal of eliciting potent B-cell and T-cell responses. PicoCELA’s platform enables the rapid design and production of vaccine candidates against infectious diseases as well as antigen-specific immunotherapies for certain cancers.

The company’s pipeline includes vaccine programs targeting SARS-CoV-2 and other respiratory pathogens, leveraging its nanoparticle scaffolds to display full-length viral spike proteins or other key antigens. Preclinical studies have demonstrated robust neutralizing antibody titers and T-cell activation in animal models, supporting progression toward clinical trials. Beyond infectious disease, PicoCELA is exploring oncology applications in which tumor-associated antigens are presented on its nanoscaffold to stimulate a targeted immune attack against cancer cells.

Founded in 2019 and headquartered in Connecticut, PicoCELA went public via a Nasdaq listing in 2021. The company collaborates with academic research centers and contract development organizations across the United States to advance its preclinical and future clinical-stage programs. PicoCELA’s leadership team comprises experienced executives and scientific founders with backgrounds in immunology, protein engineering and vaccine development, positioning the company to address unmet medical needs through its modular nanoparticle technology.

Key Stats

• Today's Range: $0.46 to $0.49
• 50-Day Range: $0.41 to $0.89
• 52-Week Range: $0.37 to $9.80
• Volume: 90,085 shs
• Average Volume: 154,519 shs
• Market Capitalization: $12.91 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PCLA Stock Analysis - Frequently Asked Questions

How have PCLA shares performed this year?

PicoCELA's stock was trading at $4.55 at the beginning of 2025. Since then, PCLA shares have decreased by 89.6% and is now trading at $0.4741.

When did PicoCELA IPO?

PicoCELA (PCLA) raised $10 million in an initial public offering (IPO) on Wednesday, January 15th 2025. The company issued 2,000,000 shares at $4.00-$6.00 per share. Benjamin Securities and Prime Number Capital acted as the underwriters for the IPO.

Who are PicoCELA's major shareholders?

PicoCELA's top institutional investors include XTX Topco Ltd (0.16%).

How do I buy shares of PicoCELA?

Shares of PCLA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/25/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Electric Lighting & Wiring Equipment
• Sub-Industry: Electrical Equipment
• Current Symbol: NASDAQ:PCLA
• CIK: 2018462
• Web: N/A
• Phone: 81 03-6661-2780
• Fax: N/A
• Employees: 53
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $5.22 million
• Price / Sales: 2.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 27,220,000
• Free Float: N/A
• Market Cap: $12.91 million
• Optionable: N/A
• Beta: N/A